The nation's top consumer, patient and labor advocates recently praised the proposed Stage 3 Meaningful Use rules, describing how they would help ensure health information technology (IT) meets the needs of patients and families.

Brilinta, Ticagrelor, PEGASUS TIMI-54, ACC, results

AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial investigating Brilinta (ticagrelor) tablets plus low dose aspirin, at the American College of Cardiology (ACC) 64 th annual scientific session and expo in March. The study compared Brilinta to placebo plus low dose aspirin, for the chronic secondary prevention of atherothrombotic events in patients who had experienced a heart attack one to three years prior to study enrolment. Study results were simultaneously published in the New England Journal of Medicine online.

University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute were the first in Ohio to implant a new device to treat right ventricular heart disease.

Professional physician associations consider certain routine tests before elective surgery to be of low value and high cost, and have sought to discourage their utilization. Nonetheless, a new national study by researchers at NYU Langone Medical Center finds that despite these peer-reviewed recommendations, no significant changes have occurred over a 14-year period in the rates of several kinds of these pre-operative tests.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now